Briefing Materials on Financial Results for the First Quarter of the Fiscal Year Ending March 2027 | GENOVA,Inc. (9341) timely disclosure

Worth reading

88Important

Scored from 4 of 6 sections

Direction

Mixed performance

Direction inferred from the company’s description.

Scale

¥100 million (year-on-year increase in net sales)

Wording

Conditional

How definitive the wording is.

Contents of this document

Presentation materials for financial resultsFirst quarter of the fiscal year ending March 20279 items taken from the company’s own explanation

Financial Results Figures (The key points of this material are explained below)

Net Sales30.5 Hundreds of millions of yen+164.7%

Operating profit-2.2 Hundreds of millions of yen

Ordinary income-2.1 Hundreds of millions of yen

Net income2.4 Hundreds of millions of yen

Operating profit margin-7.3 %

Results for the three months of the current quarterRevenue: ¥3.05 billion; operating loss: ¥220 million; ordinary loss: ¥210 million; net income attributable to owners of the parent: ¥240 million.

Full-year earnings forecast

Net Sales

216 Hundreds of millions of yen

Gross profit

92.1 Hundreds of millions of yen

Operating profit

15.7 Hundreds of millions of yen

Ordinary income

15.5 Hundreds of millions of yen

Profit attributable to owners of the parent

11.9 Hundreds of millions of yen

What the company explained in this material

Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.

Increase in investment in human capital¥131 million
Increase in recruitment expenses¥25 million
Increase in salaries and compensation¥70 million
Increase in bonuses¥29 million
Introduction of AI into human resources and recruitment operations¥7 million

New initiatives

Making 有限会社アカサカ歯材社 a subsidiary
Post-merger integration and DX/AX transformation in the dental distribution business, centralized purchasing, unified procurement, and operational efficiency improvements
Strengthening social media, presentations at medical society conferences, and recruitment communications
Brand IP collaborations and sponsorships with the Ultraman series and sports teams

Key KPIsA metric the company considers important as a management benchmark.

Number acquired this fiscal year1,289 Engagements
Year-on-year (%)130
Existing customers22,000 Approximately contracts
Average monthly PVs for Medical DOC2,184 10,000 PVs/month
Cumulative installations of Smart self-service payment and return-visit reception machines3,045 Units
Medical advisors22 People
Supervising physicians and experts2,375 People

Unit price and quantity metricsThese figures show sales broken down by price and volume.

Medical Platform customer acquisitions1,289 Engagements
Year-on-year (%)105
Medical Platform acquisition cost per customer¥1,080 thousand
Smart Clinic hardware customer acquisitions134 Engagements
Year-on-year (%)147
Smart Clinic hardware acquisition cost per customer¥2,432 thousand
Smart Clinic software customer acquisitions220 Engagements
Year-on-year (%)101
Smart Clinic software acquisition cost per customer

Segment results

Medical Platform Business
Net Sales11.4 Hundreds of millions of yen
Year-on-year (%)107.3
Operating profit2.79 Hundreds of millions of yen
Smart Clinic Business
Net Sales9.7 Hundreds of millions of yen
Year-on-year (%)144.7
Operating profit2.02 Hundreds of millions of yen
Dental Distribution Business
Net Sales8.2 Hundreds of millions of yen
Operating profit-0.7 Hundreds of millions of yen
Other
Net Sales1.1 Hundreds of millions of yen
Year-on-year (%)100

Market Size / Share

Medical and dental clinics171,000 Approximately contracts
Hospitals8,000 Approximately contracts

Number of employees

593 people including 45 part-time employees

Change during the period+64 people from the previous quarter

Annual Dividend

¥30 per share

End of period30

Payout ratio

43.6 %

Contents of this document
Item	Details
Document type	Presentation materials for financial results
Fiscal Period Covered	First quarter of the fiscal year ending March 2027
Net Sales	30.5 Hundreds of millions of yen (YoY +164.7%)
Operating profit	-2.2 Hundreds of millions of yen
Ordinary income	-2.1 Hundreds of millions of yen
Net income	2.4 Hundreds of millions of yen
Operating profit margin	-7.3 %
Results for the three months of the current quarter	Revenue: ¥3.05 billion; operating loss: ¥220 million; ordinary loss: ¥210 million; net income attributable to owners of the parent: ¥240 million.
Full-year earnings forecast	Net Sales 216 Hundreds of millions of yen / Gross profit 92.1 Hundreds of millions of yen / Operating profit 15.7 Hundreds of millions of yen / Ordinary income 15.5 Hundreds of millions of yen / Profit attributable to owners of the parent 11.9 Hundreds of millions of yen
Segment results	Segment Medical Platform Business / Net Sales 11.4 Hundreds of millions of yen / Year-on-year (%) 107.3 / Operating profit 2.79 Hundreds of millions of yen, Segment Smart Clinic Business / Net Sales 9.7 Hundreds of millions of yen / Year-on-year (%) 144.7 / Operating profit 2.02 Hundreds of millions of yen, Segment Dental Distribution Business / Net Sales 8.2 Hundreds of millions of yen / Year on year against the same period last year Not disclosed / Operating profit -0.7 Hundreds of millions of yen, Segment Other / Net Sales 1.1 Hundreds of millions of yen / Year-on-year (%) 100 / Operating profit Not disclosed
Breakdown of Factors Affecting the Change	Factors Increase in investment in human capital / Amount ¥131 million, Factors Increase in recruitment expenses / Amount ¥25 million, Factors Increase in salaries and compensation / Amount ¥70 million, Factors Increase in bonuses / Amount ¥29 million, Factors Introduction of AI into human resources and recruitment operations / Amount ¥7 million
Key KPIs	Indicator name Number acquired this fiscal year / Value 1,289 Engagements / Year-on-year (%) 130 Engagements, Indicator name Existing customers / Value 22,000 Approximately contracts / Year on year against the same period last year Not disclosed, Indicator name Average monthly PVs for Medical DOC / Value 2,184 10,000 PVs/month / Year on year against the same period last year Not disclosed, Indicator name Cumulative installations of Smart self-service payment and return-visit reception machines / Value 3,045 Units / Year on year against the same period last year Not disclosed, Indicator name Medical advisors / Value 22 People / Year on year against the same period last year Not disclosed, Indicator name Supervising physicians and experts / Value 2,375 People / Year on year against the same period last year Not disclosed
Unit price and quantity metrics	Indicator name Medical Platform customer acquisitions / Value 1,289 Engagements / Year-on-year (%) 105 Engagements, Indicator name Medical Platform acquisition cost per customer / Value ¥1,080 thousand / Year on year against the same period last year Not disclosed, Indicator name Smart Clinic hardware customer acquisitions / Value 134 Engagements / Year-on-year (%) 147 Engagements, Indicator name Smart Clinic hardware acquisition cost per customer / Value ¥2,432 thousand / Year on year against the same period last year Not disclosed, Indicator name Smart Clinic software customer acquisitions / Value 220 Engagements / Year-on-year (%) 101 Engagements, Smart Clinic software acquisition cost per customer 非開示
Number of employees	593 people (including 45 part-time employees)
Annual Dividend	¥30 per share
Payout ratio	43.6 %
Market Size / Share	Medical and dental clinics 171,000 Approximately contracts, Hospitals 8,000 Approximately contracts
New initiatives	Making 有限会社アカサカ歯材社 a subsidiary, Post-merger integration and DX/AX transformation in the dental distribution business, centralized purchasing, unified procurement, and operational efficiency improvements, Strengthening social media, presentations at medical society conferences, and recruitment communications, Brand IP collaborations and sponsorships with the Ultraman series and sports teams

Items this document does not state (13)

Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The increase in revenue was driven by the consolidation of the dental distribution business acquired through M&A, growth in PVs for the Medical Platform business, and an increase in the number of customers acquired by the Smart Clinic business. The wider operating loss was due to a ¥131 million year-on-year increase in investment in human capital and the high proportion of manufacturing expenses and personnel expenses following ASANO's integration into the Group. The return to net profitability was due to ¥490 million in extraordinary income from the waiver of stock acquisition rights.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.